Rapid Pathogen Screening Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Rapid Pathogen Screening Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10356
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rapid Pathogen Screening Inc (RPS) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography (DMC) technology to develop various tests. Its products portfolio includes FebriDx, a test that uses a fingerstick blood sample to support differentiate viral from bacterial acute febrile respiratory infection; AdenoPlus, a CLIA-waived, point-of-care test that identifies serotypes of adenoviral conjunctivitis; and the InflammaDry test for dry eye. The company develops solutions for infectious diseases and inflammatory conditions. It also offers bio-terrorism and chemical nerve agent blood toxin solutions. RPS is headquartered in Sarasota, Florida, the US.

Rapid Pathogen Screening Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Rapid Pathogen Screening Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
Partnerships 14
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 14
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 15
Rapid Pathogen Screening and Atomo Diagnostics Enter into Development Partnership 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Asset Transactions 18
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc – Key Competitors 19
Rapid Pathogen Screening Inc – Key Employees 20
Rapid Pathogen Screening Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Rapid Pathogen Screening Inc, Medical Equipment, Key Facts 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rapid Pathogen Screening Inc, Deals By Market, 2012 to YTD 2018 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 14
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 15
Rapid Pathogen Screening and Atomo Diagnostics Enter into Development Partnership 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc, Key Competitors 19
Rapid Pathogen Screening Inc, Key Employees 20

List of Figures
Rapid Pathogen Screening Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Rapid Pathogen Screening Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Rapid Pathogen Screening Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Rapid Pathogen Screening Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AIG Europe Limited:企業の戦略・SWOT・財務情報
    AIG Europe Limited - Strategy, SWOT and Corporate Finance Report Summary AIG Europe Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Anheuser-Busch InBev NVSA (ABI):企業の財務・戦略的SWOT分析
    Anheuser-Busch InBev NVSA (ABI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • LivaNova PLC (LIVN):製品パイプライン分析
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by trea …
  • Foundation for Innovative New Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Mtr Corporation Ltd:企業の戦略・SWOT・財務分析
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CNTEE Transelectrica S.A.:発電所・企業SWOT分析
    CNTEE Transelectrica S.A. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Hess Corp (HES):企業の財務・戦略的SWOT分析
    Hess Corp (HES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ballard Power Systems Inc (BLDP):企業の財務・戦略的SWOT分析
    Ballard Power Systems Inc (BLDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Debiopharm International SA-製薬・医療分野:企業M&A・提携分析
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆